Why the study?
Does AKAP Yotiao alter the function of the I(Ks) heart potassium channel downstream of PKA phosphorylation?
Does AKAP Yotiao alter the function of the I(Ks) heart potassium channel downstream of PKA phosphorylation?
The AKAP Yotiao acts as an effector to directly regulate the I(Ks) potassium channel subsequent to PKA phosphorylation, revealing a novel mechanism relevant to long QT syndrome.
AKAP Yotiao may directly modulate I(Ks) beyond PKA; leaves open mechanistic and therapeutic roles in long QT syndrome pending human validation.
A-kinase anchoring proteins (AKAPs) are thought to be passive members of protein complexes that coordinate the association of cAMP-dependent protein kinase A (PKA) with cellular substrates to facilitate targeted PKA protein phosphorylation. I(Ks), the slow heart potassium current, is carried by the I(Ks) potassium channel, a substrate for PKA phosphorylation in response to sympathetic nerve stimulation, is a macromolecular complex that includes the KCNQ1 alpha subunit, the KCNE1 regulatory subunit, and the AKAP Yotiao. Disruption of this regulation by mutation in the long QT syndrome is associated with elevated risk of sudden death. Here, we have studied the effects of the AKAP Yotiao on the function of the I(Ks) channel that had been mutated to simulate channel phosphorylation, and we report direct AKAP-mediated alteration of channel function distinct from its role in the coordination of channel phosphorylation by PKA. These data reveal previously undescribed actions of Yotiao that occur subsequent to channel phosphorylation and provide evidence that this adaptor protein also may serve as an effector in regulating this important ion channel.
No takes yet. Share an insight, caveat, or question.
Kurokawa et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: